OCREVUS solución concentrada para infusión intravenosa Uruguay - İspanyolca - Ministerio de Salud (Dirección Oficina Central)

ocrevus solución concentrada para infusión intravenosa

roche - solución concentrada para infusión intravenosa - ocrelizumab 300 mg/10 ml (30 mg/ml) inyectable

Idefirix Avrupa Birliği - İspanyolca - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - inmunosupresores - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.